166 related articles for article (PubMed ID: 36323332)
1. Advanced serrated polyps as a target of screening: detection rate and positive predictive value within a fecal immunochemical test-based colorectal cancer screening population.
van Toledo DEFWM; Breekveldt ECH; IJspeert JEG; van Vuuren AJ; van Kemenade FJ; Ramakers C; Nagtegaal ID; van Leerdam ME; Spaander MCW; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Dekker E
Endoscopy; 2023 Jun; 55(6):526-534. PubMed ID: 36323332
[TBL] [Abstract][Full Text] [Related]
2. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
3. Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals.
Álvarez C; Andreu M; Castells A; Quintero E; Bujanda L; Cubiella J; Salas D; Lanas Á; Carballo F; Morillas JD; Hernández C; Jover R; Sarasqueta C; Enriquéz-Navascués JM; Hernández V; Estévez P; Macenlle R; Sala T; Balaguer F; Pellisé M; Moreira L; Gil I; Peris A; González-Rubio F; Ferrández A; Poves C; Ponce M; Grau J; Serradesanferm A; Ono A; Cruzado J; Pérez-Riquelme F; Alonso-Abreu I; Carrillo-Palau M; Santander C; Díaz Tasende J; Herreros A; Cacho G; Barranco LE; Bessa X;
Gastrointest Endosc; 2013 Aug; 78(2):333-341.e1. PubMed ID: 23623039
[TBL] [Abstract][Full Text] [Related]
4. Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps.
He X; Hang D; Wu K; Nayor J; Drew DA; Giovannucci EL; Ogino S; Chan AT; Song M
Gastroenterology; 2020 Mar; 158(4):852-861.e4. PubMed ID: 31302144
[TBL] [Abstract][Full Text] [Related]
5. Long-term risk of colorectal cancer in individuals with serrated polyps.
Holme Ø; Bretthauer M; Eide TJ; Løberg EM; Grzyb K; Løberg M; Kalager M; Adami HO; Kjellevold Ø; Hoff G
Gut; 2015 Jun; 64(6):929-36. PubMed ID: 25399542
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
[TBL] [Abstract][Full Text] [Related]
7. Findings in the distal colorectum are not associated with proximal advanced serrated lesions.
Kahi CJ; Vemulapalli KC; Snover DC; Abdel Jawad KH; Cummings OW; Rex DK
Clin Gastroenterol Hepatol; 2015 Feb; 13(2):345-51. PubMed ID: 25083562
[TBL] [Abstract][Full Text] [Related]
8. Detection rate and proximal shift tendency of adenomas and serrated polyps: a retrospective study of 62,560 colonoscopies.
Chen S; Sun K; Chao K; Sun Y; Hong L; Weng Z; Cui Y; Chen M; Zhang S
Int J Colorectal Dis; 2018 Feb; 33(2):131-139. PubMed ID: 29282495
[TBL] [Abstract][Full Text] [Related]
9. Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening.
Bronzwaer MES; Greuter MJE; Bleijenberg AGC; IJspeert JEG; Dekker E; Coupé VMH
BMC Cancer; 2018 Apr; 18(1):465. PubMed ID: 29695244
[TBL] [Abstract][Full Text] [Related]
10. Contribution of the OC Sensor
Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX
Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of adenomatous polyposis in a fecal immunochemical test-based colorectal cancer screening program and risk of advanced neoplasia during follow-up.
Carballal S; Sánchez A; Moreira L; Cuellar-Monterrubio JE; Bernuy J; Daca M; Ortiz O; Ocaña T; Rivero-Sánchez L; Jung G; Serradesanferm A; Pozo A; Grau J; Torá I; Zaffalon D; Castells A; Pellisé M; Balaguer F;
Endoscopy; 2022 Jul; 54(7):688-697. PubMed ID: 34607378
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
[No Abstract] [Full Text] [Related]
13. Serrated Lesion Detection in a Population-based Colon Screening Program.
Chu JE; Hamm J; Gentile L; Telford JJ; Schaeffer DF
J Clin Gastroenterol; 2022 Mar; 56(3):243-248. PubMed ID: 33780220
[TBL] [Abstract][Full Text] [Related]
14. Adenoma and Sessile Serrated Lesion Detection Rates at Screening Colonoscopy for Ages 45-49 Years vs Older Ages Since the Introduction of New Colorectal Cancer Screening Guidelines.
Ladabaum U; Shepard J; Mannalithara A
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2895-2904.e4. PubMed ID: 35580769
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer risk after removal of polyps in fecal immunochemical test based screening.
van Toledo DEFWM; IJspeert JEG; Spaander MCW; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I; Dekker E
EClinicalMedicine; 2023 Jul; 61():102066. PubMed ID: 37528844
[TBL] [Abstract][Full Text] [Related]
16. The significance of the small adenoma: a longitudinal study of surveillance colonoscopy in an Australian population.
Symonds EL; Cole SR; Lau SY; Steele S; Meng R; Woodman RJ; Young GP; Cock C; Fraser R; Bampton P
Eur J Gastroenterol Hepatol; 2019 May; 31(5):563-569. PubMed ID: 30672827
[TBL] [Abstract][Full Text] [Related]
17. Data quality and colonoscopy performance indicators in the prevalent round of a FIT-based colorectal cancer screening program.
Lund M; Erichsen R; Valori R; Møller Jensen T; Helle Njor S; Laurberg S; Andersen B;
Scand J Gastroenterol; 2019 Apr; 54(4):471-477. PubMed ID: 30978128
[No Abstract] [Full Text] [Related]
18. Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry.
Anderson JC; Butterly LF; Weiss JE; Robinson CM
Gastrointest Endosc; 2017 Jun; 85(6):1188-1194. PubMed ID: 28153571
[TBL] [Abstract][Full Text] [Related]
19. Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; de Pretis G; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex DK; Zappa M; Hassan C;
Gut; 2017 Jul; 66(7):1233-1240. PubMed ID: 26896459
[TBL] [Abstract][Full Text] [Related]
20. Effects of Oral Anticoagulants and Aspirin on Performance of Fecal Immunochemical Tests in Colorectal Cancer Screening.
Randel KR; Botteri E; Romstad KMK; Frigstad SO; Bretthauer M; Hoff G; de Lange T; Holme Ø
Gastroenterology; 2019 May; 156(6):1642-1649.e1. PubMed ID: 30689972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
